Bal Pharma Standalone September 2023 Net Sales at Rs 92.30 crore, up 22.98% Y-o-Y
09-11-2023
BAL PHARMA LTD. - 524824 - Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2023.
The Board of Directors of the Company has inter alia taken on record and approved the unaudited financial result of the Company for the quarter and half year ended 30.09.202308-11-2023
BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting
Board of Directors of the Company has met today and inter alia transacted the following business. 1.Taken on record and approved the Un-audited standalone and consolidated financial results of the Company for the quarter and half year ended 30.09.2023. A copy of the approved financial results together with the limited review report issued by the statutory auditors of the Company with unmodified opinion is enclosed with this intimation. 2. Approved the allotment of 1,18,500 Equity shares to the employees of the Company who has exercised the employee stock options vested on them. 3. Approved the grant of 1,83,500 stock options to the eligible employees of the Company from 'Bal Pharma Ltd-Employee stock option plan-2014'. The meeting of the Board has commenced at 4.45 p.m. and concluded at 5.40 p.m on Wednesday, 8th November 2023.08-11-2023
BAL PHARMA LTD. - 524824 - Board Meeting Intimation for Inter Alia Take On Record And Approve The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended 30.09.2023.
BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter and half year ended 30.09.2023. 2.Allotment of equity shares to the employees of the Company who has exercised the conversion option on employee stock options vested on them. 3. To grant stock options under Bal Pharma Ltd-Employee stock option scheme 2014 , to the eligible employees of the Company.20-10-2023
BAL PHARMA LTD. - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Based on the certifications received from our R&T agents i.e TSR Darashaw Pvt Ltd, We hereby submit our confirmation as required under Regulation 74(5) of SEBI (DP) Regulations , for the quarter ended 30.09.2023.03-10-2023
BAL PHARMA LTD. - 524824 - Closure of Trading Window
Pursuant to the Code of Conduct of the Company and as per the provisions of SEBI(Prohibition of Insider Trading) Regulations,2015, We wish to inform the exchanges that the trading window for dealing with the securities of the Company on the designated employees of the Company and their immediate relatives will be closed from 1st October 2023 and up to 48 hours of declaration of un-audited financial results of the Company for the quarter and half year ended 30.09.2023 The date of the Board meeting for declaration of the financial results will be intimated to the exchanges in due course.28-09-2023
BAL PHARMA LTD. - 524824 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We are submitting to the exchange the results of the remove e-voting for 36th Annual General Meeting of the Company held on 25.09.2023 with a copy of scrutinizers report.27-09-2023
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Dividend Updates
Members of the Company at 36th Annual General Meeting of the Company held on 25.09.2023 has declared a dividend of Re.1/- per equity share of Rs.10/- each, for the financial year 2022-23.25-09-2023
BAL PHARMA LTD. - 524824 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to the provisions of Regulation 30 of SEBI(LODR) Regulations,2015, We are submitting to the exchange business transacted at 36th Annual General Meeting of the Company conducted through audio visual means, on 25.09.2023.25-09-2023
BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are submitting to the exchanges copies of newspaper advertisements pertaining to Notice for the 36th Annual General Meeting of the Company scheduled on 25th September 2023, remote e-voting intimation and book closure intimation published in "Financial Express" (English Language) and Sanjay Vani (Kannada language) , on 31.08.2023.01-09-2023